NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research

        • Research Overview
        • Clinical Research Facility
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient & Public Involvement
    • Getting involved with research
    • View and register for involvement opportunities
    • Patient & Public Groups
    • Patient and Public Involvement Advisory Group
    • Diversity in Research Group
    • Oxford Blood Group
    • Case Studies
    • PPIE Strategy
    • PPIE News
    • PPI Researcher Guidance
    • Researchers: Post a PPIE opportunity
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events
Research Theme

Genomic Medicine

You are here: Home > Research Overview > Genomic Medicine > Sub-theme 2: Predictive and personalised medicine

Sub-theme 2: Predictive and personalised medicine

Led by Professor Julian Knight

While with rare diseases, one genetic mutation could be responsible, it is often the case that the incremental effects of lots of different genes lead to common health conditions such as cancers or cardiovascular disease.

We are developing polygenic risk scores that can assess different genes and tell you where you are on a risk profile, and what is the likelihood of you getting a disease. We are working to understand how we can refine this tool to use it in the clinic – including primary care – to identify people who are at highest risk.

This will include incorporating other factors beyond the DNA sequence – a so-called multi-omics approach that takes in transcriptomics, metabolomics or proteomics. This allows us to understand how the genome is put together and regulated.

This richer data will allow us to prioritise those patients most at risk of these common conditions and lead to more targeted therapies.

We are working towards getting the evidence that shows PRS is a vital clinical tool for predicting the risk of common diseases. We are building a large, ethnically diverse cohort by working with the Our Future Health (OFH) programme

We are also using the expertise of a number of BRC themes, including Translational Data Science, to refine the PRS method and to determine those areas most likely to translate well to a clinical setting, such as the early detection of cancers in primary care; risk stratification for prostate and colorectal cancers; and cardiovascular diseases.

We are developing genetic and ‘-omic’-derived biomarkers – molecules found in the blood or tissues that can be an early sign of a disease – that can eventually be used in the clinical setting to detect a medical condition.

One aspect of this will be to stratify acute medical patients with infection and critical illness by comparing their multi-omic data against phenotype – their observable characteristics – to enable a targeted intervention. This will entail close collaboration with a number of other BRC themes.

Genomic Medicine

  • Genomic Medicine
  • Sub-theme 1: Variant to Function to Diagnosis and Therapy
  • Sub-theme 2: Predictive and personalised medicine
  • Sub-theme 3: Bridging and enabling translation
  • Contacts
  • Videos
  • PPI Case Study
  • News

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre